October 2019

NASH and Liver Cancer: The New Cancer Headline

October 15, 2019

Evidence-Based Oncology

The most common primary liver cancer, hepatocellular carcinoma, is driven by fatty liver disease and is among the most prevalent and deadly of cancers driven by obesity. Rising rates of overweight and obesity parallel increased rates of obesogenic cancers, which increased 7% between 2005 and 2014.

Obesity and Cancer Risk: A Public Health Crisis

October 16, 2019

Evidence-Based Oncology

Obesity is associated with a number of adverse health-related complications and carries an elevated individual all-cause mortality risk. It would be hard to overstate the increased adverse health outcomes for obese individuals. What is far less well recognized by the general public is the significant link between obesity and increased cancer risk.

How Obesity Affects Cancer Treatment, and How to Talk With Patients About Prevention

October 17, 2019

Evidence-Based Oncology

Debra Patt, MD, MPH, MBA, an oncologist who specializes in breast cancer and who serves as executive vice president at Texas Oncology, discusses the effect of obesity on cancer treatment as well as prevention strategies.

Screening and Prevention: More Data Reveal Shift to Obesity-Related Cancers in Younger Patients

October 17, 2019

Evidence-Based Oncology

Although results of other recent studies have noted the rise in the rate of obesity-related cancers among younger adults, this is the first study to also find a concurrent decrease in the rate of new cancer cases among patients 65 years and older.

ASTRO Calls for Voluntary Start, Scaling Back Excessive Cuts in CMS' Proposed Radiation Oncology Model

October 17, 2019

Evidence-Based Oncology

In a commentary adapted from the organization's official response to CMS' proposal, the author highlights potential challenges that proposed alternative payment model presents for members of the American Society for Radiation Oncology (ASTRO).

Conference Coverage: NCCN Policy Summit September 2019

October 20, 2019

Evidence-Based Oncology

Speakers at the September 12, 2019, Policy Summit of the National Comprehensive Cancer Center, held in Washington, DC, addressed what practices have learned from experience with the Oncology Care Model and what steps must occur to standardize patient reported outcomes to incorporate them into reporting.

AJMCtv October 2019

October 20, 2019

Evidence-Based Oncology

AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers—from the clinician, to the health plan leader, to the regulator.